Department of Medical Assistance Services
Board of Medical Assistance Services
Electronic Access
Meeting:
Pharmacy and Therapeutics Meetiing
| Meeting Details | |
|---|---|
| Date / Time | 1/29/2026 1:00 pm |
| Type | Electronic Only |
| Electronic Access | Join via Teams: https://teams.microsoft.com/l/meetup-join/19%3ameeting_N2VlZTY5ZGItMDYzNy00MWJjLWE3ODUtMmI0MmQwNmZmZjkw%40thread.v2/0?context=%7b%22Tid%22%3a%22620ae5a9-4ec1-4fa0-8641-5d9f386c7309%22%2c%22Oid%22%3a%22a02e1198-b63c-4beb-a86d-216f8ad791bf%22%7d Meeting ID: 271 226 114 049 Passcode: pJ9KG3kK Dial in (audio only): +1 434 230 0065,,44214369# |
| Board Website | https://www.dmas.virginia.gov/about-us/boards-and-public-meetings/board-of-medical-assistance-services |
| Agenda document |
Meeting Agenda
12/19/2025
(230k)
|
| Minutes document | agency has not posted |
| Purpose of the meeting The DMAS Pharmacy and Therapeutics (P&T) Committee is an interdisciplinary group of healthcare professionals responsible for developing and maintaining the program's preferred drug list (PDL) or common core formulary (CCF). The committee's primary function is to review and evaluate the clinical evidence of drugs to ensure that the medications covered by the program are safe, effective, and cost-efficient. The P&T committee ensures that Medicaid beneficiaries have access to a comprehensive and appropriate range of medications. | |
| Meeting Scope |
Public hearing to receive comment on a proposed stage
X
General business of the board
Discuss particular regulations / chapters
|
| Contact Information | |
|---|---|
| Name / Title: | JoeMichael T. Fusco, PharmD / Pharmacy Operations Manager |
| Address: |
600 E. Broad St., Suite 1300 Richmond, 23219 |
| Email Address: | joemichael.fusco@dmas.virginia.gov |
| Telephone: | (804)929-3261 FAX: (804)786-1680 TDD: ()- |
| Reasonable accommodations for people with disabilities, such as sign language interpreters and/or real-time captioning services, are available upon request. Please send accommodation requests to the meeting contact as early as possible but no later than seven business days before the date of the meeting. | |